MENU
*th International Conference on ****
Program List
Opening Ceremony
Date
November 29 (Sat.), 2025 08:30 - 09:00
Room
Room 1(TICC 3F Main Hall)
Chairperson
OP-1
Deutsch-JozsaDeutsch-JozsaDeutsch-JozsaDeutsch-JozsaDeutsch-JozsaDeutsch-Jozsa
Opening Lecture
OP-1
Deutsch-JozsaDeutsch-JozsaDeutsch-JozsaDeutsch-JozsaDeutsch-JozsaDeutsch-Jozsa
Opening Lecture
Speaker
Taro Yamada(A Univ.)
Plenary 1
Date
November 29 (Sat.), 2025 09:00 - 10:00
Room
Room 1(TICC 3F Main Hall)
Chairperson
PL-1
Advances in Precision Medicine for Cancer Treatment
Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Maecenas p
PL-1
Advances in Precision Medicine for Cancer Treatment
Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Maecenas p
Speaker
Liam Smith(Global Medical Research Institute)
Plenary 2
Date
November 30 (Sun.), 2025 09:00 - 10:00
Room
Room 1(TICC 3F Main Hall)
Chairperson
PL-2
Novel Biomarkers for Early Detection of Alzheimer's Disease
Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Maecenas p
PL-2
Novel Biomarkers for Early Detection of Alzheimer's Disease
Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Maecenas p
Speaker
Olivia Johnson(Sunrise Healthcare Corporation)
Poster
Date
November 30 (Sun.), 2025 13:30 - 15:30
Room
Poster(TICC 1F Gallery)
Chairperson
P1-1
〇〇産業における〇〇問題への対応策
このポスターはこのような内容です。
P1-1
〇〇産業における〇〇問題への対応策
このポスターはこのような内容です。
Speaker
Hanako Endai(Dummy Test Co., Ltd.)
P1-2
〇〇の最新研究と展望
This poster shows the result of this research.
P1-2
〇〇の最新研究と展望
This poster shows the result of this research.
Speaker
Saburo Nihon(TestDummy Co., Ltd.)
P1-3
〇〇の方法論とその実践
Fusce est. Vivamus a tellus. Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Proin pharetra nonummy pede.
P1-3
〇〇の方法論とその実践
Fusce est. Vivamus a tellus. Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Proin pharetra nonummy pede.
Speaker
test test(A)
P1-4
〇〇における〇〇の報告について
Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Maecenas p
P1-4
〇〇における〇〇の報告について
Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Maecenas p
Speaker
Naoko Miyashita(PCO)
P1-5
Qiskitを用いた量子プログラミングについて
us lectus malesuada libero, sit amet commodo magna eros quis urna. Nunc viverra imperdiet enim.
P1-5
Qiskitを用いた量子プログラミングについて
us lectus malesuada libero, sit amet commodo magna eros quis urna. Nunc viverra imperdiet enim.
Speaker
Asuka Yamamoto(ooCo.,Ltd)
P1-6
Deutsch-Jozsaのアルゴリズムについて
Fusce est. Vivamus a tellus. Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Proin pharetra nonummy pede.
P1-6
Deutsch-Jozsaのアルゴリズムについて
Fusce est. Vivamus a tellus. Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Proin pharetra nonummy pede.
Speaker
Yuto Kanemoto(ooUniversity)
P1-7
現実における量子テレポーテーションの活用法について
Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Maecenas p
P1-7
現実における量子テレポーテーションの活用法について
Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Maecenas p
Speaker
Nana Inoue(triUniversity)
P2-1
動的計画法とナップザック問題について
us lectus malesuada libero, sit amet commodo magna eros quis urna. Nunc viverra imperdiet enim.
P2-1
動的計画法とナップザック問題について
us lectus malesuada libero, sit amet commodo magna eros quis urna. Nunc viverra imperdiet enim.
Speaker
Naoto Sasaki(xxCo.,Ltd)
P2-2
Bellの不等式とその破れについて
Fusce est. Vivamus a tellus. Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Proin pharetra nonummy pede.
P2-2
Bellの不等式とその破れについて
Fusce est. Vivamus a tellus. Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Proin pharetra nonummy pede.
Speaker
Hiroyuki Kato(tri_Co.,Ltd)
P2-3
確率的な期待値と人間の感覚としての期待値の相関について
Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Maecenas p
P2-3
確率的な期待値と人間の感覚としての期待値の相関について
Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Maecenas p
Speaker
Yuri Uchida(xxUniversity)
P2-4
ハーフミラーによる干渉がもたらす量子の性質について
us lectus malesuada libero, sit amet commodo magna eros quis urna. Nunc viverra imperdiet enim.
P2-4
ハーフミラーによる干渉がもたらす量子の性質について
us lectus malesuada libero, sit amet commodo magna eros quis urna. Nunc viverra imperdiet enim.
Speaker
Syuichi Emoto(sq_Co.,Ltd)
P2-5
リー代数と群論について
Fusce est. Vivamus a tellus. Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Proin pharetra nonummy pede.
P2-5
リー代数と群論について
Fusce est. Vivamus a tellus. Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Proin pharetra nonummy pede.
Speaker
Akio Murakami(sqUniversity)
P2-6
BFS及びDFSを用いた問題解決について
us lectus malesuada libero, sit amet commodo magna eros quis urna. Nunc viverra imperdiet enim.
P2-6
BFS及びDFSを用いた問題解決について
us lectus malesuada libero, sit amet commodo magna eros quis urna. Nunc viverra imperdiet enim.
Speaker
Ayaka Sugiyama(di_Co.,Ltd)
P2-7
人間のコミュニティの繁栄と衰退について
Fusce est. Vivamus a tellus. Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Proin pharetra nonummy pede.
P2-7
人間のコミュニティの繁栄と衰退について
Fusce est. Vivamus a tellus. Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Proin pharetra nonummy pede.
Speaker
Iroha Maeda(diUniversity)
Oral Session 1
Machine Learning Algorithms
Machine Learning Algorithms
Details
Date
November 29 (Sat.), 2025 10:30 - 12:00
Room
Room 1(TICC 3F Main Hall)
Chairperson
OS1-1
Artificial Intelligence in Radiological Diagnosis
Fusce est. Vivamus a tellus. Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Proin pharetra nonummy pede.
OS1-1
Artificial Intelligence in Radiological Diagnosis
Fusce est. Vivamus a tellus. Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Proin pharetra nonummy pede.
Speaker
Noah Williams(Horizon Medical Center)
OS1-2
Clinical Applications of Gene Editing Technologies
us lectus malesuada libero, sit amet commodo magna eros quis urna. Nunc viverra imperdiet enim.
OS1-2
Clinical Applications of Gene Editing Technologies
us lectus malesuada libero, sit amet commodo magna eros quis urna. Nunc viverra imperdiet enim.
Speaker
Emma Brown(Advanced Biomedical Solutions)
OS1-3
Immunotherapy Strategies in Solid Tumors
Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Maecenas p
OS1-3
Immunotherapy Strategies in Solid Tumors
Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Maecenas p
Speaker
Oliver Jones(Nova Health Sciences Group)
OS1-4
Recent Progress in Cardiovascular Disease Management
us lectus malesuada libero, sit amet commodo magna eros quis urna. Nunc viverra imperdiet enim.
OS1-4
Recent Progress in Cardiovascular Disease Management
us lectus malesuada libero, sit amet commodo magna eros quis urna. Nunc viverra imperdiet enim.
Speaker
Ava Garcia(Central Medical Innovation Lab)
Oral Session 2
User Experience Design
User Experience Design
Details
Date
November 29 (Sat.), 2025 10:30 - 12:00
Room
Room 2(TICC 2F 201-204)
Chairperson
OS2-1
Machine Learning Approaches in Drug Discovery
Fusce est. Vivamus a tellus. Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Proin pharetra nonummy pede.
OS2-1
Machine Learning Approaches in Drug Discovery
Fusce est. Vivamus a tellus. Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Proin pharetra nonummy pede.
Speaker
Elijah Miller(United Health Systems Inc.)
OS2-2
Emerging Therapies for Type 2 Diabetes Mellitus
Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Maecenas p
OS2-2
Emerging Therapies for Type 2 Diabetes Mellitus
Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Maecenas p
Speaker
Sophia Davis(Future Care Medical Institute)
OS2-3
Regenerative Medicine and Stem Cell Therapy
us lectus malesuada libero, sit amet commodo magna eros quis urna. Nunc viverra imperdiet enim.
OS2-3
Regenerative Medicine and Stem Cell Therapy
us lectus malesuada libero, sit amet commodo magna eros quis urna. Nunc viverra imperdiet enim.
Speaker
James Rodriguez(Pacific Medical Research Center)
OS2-4
COVID-19: Long-term Effects and Clinical Outcomes
Fusce est. Vivamus a tellus. Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Proin pharetra nonummy pede.
OS2-4
COVID-19: Long-term Effects and Clinical Outcomes
Fusce est. Vivamus a tellus. Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Proin pharetra nonummy pede.
Speaker
Isabella Martinez(Elite Healthcare Corporation)
Oral Session 3
Accessibility & Inclusive Design
Accessibility & Inclusive Design
Details
Date
November 29 (Sat.), 2025 10:30 - 12:00
Room
Room 3(TICC 2F 205-206)
Chairperson
OS3-1
Telemedicine in Modern Healthcare Systems
Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Maecenas p
OS3-1
Telemedicine in Modern Healthcare Systems
Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Maecenas p
Speaker
Benjamin Hernandez(Apex Biomedical Research Institute)
OS3-2
Microbiome Influence on Human Health and Disease
us lectus malesuada libero, sit amet commodo magna eros quis urna. Nunc viverra imperdiet enim.
OS3-2
Microbiome Influence on Human Health and Disease
us lectus malesuada libero, sit amet commodo magna eros quis urna. Nunc viverra imperdiet enim.
Speaker
Mia Lopez(Greenfield Medical Technologies)
OS3-3
Personalized Treatment in Oncology Practice
Fusce est. Vivamus a tellus. Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Proin pharetra nonummy pede.
OS3-3
Personalized Treatment in Oncology Practice
Fusce est. Vivamus a tellus. Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Proin pharetra nonummy pede.
Speaker
Lucas Gonzalez(International Health Alliance)
OS3-4
Neurodegenerative Disease Mechanisms and Treatment
Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Maecenas p
OS3-4
Neurodegenerative Disease Mechanisms and Treatment
Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Maecenas p
Speaker
Charlotte Wilson(Summit Medical Group)
Oral Session 4
Renewable Energy Systems
Renewable Energy Systems
Details
Date
November 30 (Sun.), 2025 09:30 - 11:00
Room
Room 1(TICC 3F Main Hall)
Chairperson
OS4-1
Advances in Minimally Invasive Surgical Techniques
us lectus malesuada libero, sit amet commodo magna eros quis urna. Nunc viverra imperdiet enim.
OS4-1
Advances in Minimally Invasive Surgical Techniques
us lectus malesuada libero, sit amet commodo magna eros quis urna. Nunc viverra imperdiet enim.
Speaker
Henry Anderson(PrimeCare Medical Solutions)
OS4-2
Antibiotic Resistance: Global Challenges and Solutions
Fusce est. Vivamus a tellus. Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Proin pharetra nonummy pede.
OS4-2
Antibiotic Resistance: Global Challenges and Solutions
Fusce est. Vivamus a tellus. Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Proin pharetra nonummy pede.
Speaker
Amelia Thomas(BlueSky Health Research Center)
OS4-3
Digital Health Transformation in Clinical Practice
Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Maecenas p
OS4-3
Digital Health Transformation in Clinical Practice
Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Maecenas p
Speaker
Alexander Taylor(Vertex Medical Innovations)
OS4-4
Biomarkers in Early Cancer Screening
us lectus malesuada libero, sit amet commodo magna eros quis urna. Nunc viverra imperdiet enim.
OS4-4
Biomarkers in Early Cancer Screening
us lectus malesuada libero, sit amet commodo magna eros quis urna. Nunc viverra imperdiet enim.
Speaker
Harper Moore(Global Life Sciences Institute)
Oral Session 5
Circular Economy Solutions
Circular Economy Solutions
Details
Date
November 30 (Sun.), 2025 09:30 - 11:00
Room
Room 2(TICC 2F 201-204)
Chairperson
OS5-1
Precision Immunology in Autoimmune Diseases
Fusce est. Vivamus a tellus. Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Proin pharetra nonummy pede.
OS5-1
Precision Immunology in Autoimmune Diseases
Fusce est. Vivamus a tellus. Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Proin pharetra nonummy pede.
Speaker
Daniel Jackson(Meditech Research Corporation)
OS5-2
Cardiac Imaging Innovations and Applications
Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Maecenas p
OS5-2
Cardiac Imaging Innovations and Applications
Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Maecenas p
Speaker
Evelyn Martin(Harmony Healthcare Group)
OS5-3
CRISPR-Based Therapies: Current Status and Future Prospects
us lectus malesuada libero, sit amet commodo magna eros quis urna. Nunc viverra imperdiet enim.
OS5-3
CRISPR-Based Therapies: Current Status and Future Prospects
us lectus malesuada libero, sit amet commodo magna eros quis urna. Nunc viverra imperdiet enim.
Speaker
Matthew Lee(NextGen Medical Institute)
OS5-4
AI-Assisted Pathology in Clinical Diagnosis
Fusce est. Vivamus a tellus. Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Proin pharetra nonummy pede.
OS5-4
AI-Assisted Pathology in Clinical Diagnosis
Fusce est. Vivamus a tellus. Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Proin pharetra nonummy pede.
Speaker
Abigail Perez(Crestview Biomedical Center)
OS5-5
Advances in Pediatric Disease Management
Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Maecenas p
OS5-5
Advances in Pediatric Disease Management
Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Maecenas p
Speaker
Samuel Thompson(Aurora Medical Research Lab)
Oral Session 6
Environmental Monitoring
Environmental Monitoring
Details
Date
November 30 (Sun.), 2025 09:30 - 11:00
Room
Room 3(TICC 2F 205-206)
Chairperson
OS6-1
Pharmacogenomics and Individualized Drug Therapy
us lectus malesuada libero, sit amet commodo magna eros quis urna. Nunc viverra imperdiet enim.
OS6-1
Pharmacogenomics and Individualized Drug Therapy
us lectus malesuada libero, sit amet commodo magna eros quis urna. Nunc viverra imperdiet enim.
Speaker
Emily White(VitalCore Health Systems)
OS6-2
New Frontiers in Infectious Disease Research
Fusce est. Vivamus a tellus. Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Proin pharetra nonummy pede.
OS6-2
New Frontiers in Infectious Disease Research
Fusce est. Vivamus a tellus. Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Proin pharetra nonummy pede.
Speaker
David Harris(NorthStar Medical Sciences)
OS6-3
Stem Cell Applications in Tissue Engineering
Fusce est. Vivamus a tellus. Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Proin pharetra nonummy pede.
OS6-3
Stem Cell Applications in Tissue Engineering
Fusce est. Vivamus a tellus. Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Proin pharetra nonummy pede.
Speaker
Ella Sanchez(Everwell Healthcare Institute)
OS6-4
Big Data Analytics in Healthcare Systems
Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Maecenas p
OS6-4
Big Data Analytics in Healthcare Systems
Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Maecenas p
Speaker
Joseph Clark(OmniHealth Research Corporation)
OS6-5
Respiratory Disease Management in the Post-Pandemic Era
us lectus malesuada libero, sit amet commodo magna eros quis urna. Nunc viverra imperdiet enim.
OS6-5
Respiratory Disease Management in the Post-Pandemic Era
us lectus malesuada libero, sit amet commodo magna eros quis urna. Nunc viverra imperdiet enim.
Speaker
Scarlett Ramirez(ClearView Medical Solutions)
OS6-6
Novel Approaches in Stroke Rehabilitation
Fusce est. Vivamus a tellus. Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Proin pharetra nonummy pede.
OS6-6
Novel Approaches in Stroke Rehabilitation
Fusce est. Vivamus a tellus. Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Proin pharetra nonummy pede.
Speaker
Sebastian Lewis(BioFrontier Medical Institute)